Trial site
Jichi Medical University Hospital
- 21running trials
- 11closed trials
The trials here
What the 32 trials at this site are about, from their registry records.
- Conditions
- Stroke5 trials
- Ulcerative colitis5 trials
- Crohn's disease4 trials
- Metastatic breast cancer4 trials
- High blood pressure2 trials
- Childhood cancers1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Diabetic eye disease1 trial
- Epilepsy1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Head and neck cancer1 trial
- Macular degeneration1 trial
- and 4 more
- Phase
- Phase 318 trials
- Phase 27 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Completed11 trials
- Recruiting11 trials
- Active, not recruiting10 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Janssen Research & Development, LLC4 trials
- Pfizer3 trials
- Celgene2 trials
- Janssen Pharmaceutical K.K.2 trials
- and 14 more
Running trials
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
Recruiting
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Recruiting
Active, not recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab
Recruiting
Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
Active, not recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Active, not recruiting
Recruiting
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Active, not recruiting
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting
Active, not recruiting
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke3 recruiting
- Childhood cancers1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroblastoma1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
Completed
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Completed
Completed
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Completed
Completed
Completed
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026